Hypoglossal Nerve Stimulation (Inspire Therapy) for Obstructive Sleep Apnea
Yes, Inspire hypoglossal nerve stimulation is indicated for this patient and should be discussed as a treatment option, as they meet all eligibility criteria and have failed CPAP therapy. 1
Strong Recommendation for Surgical Referral
The 2021 American Academy of Sleep Medicine clinical practice guideline provides a STRONG recommendation that clinicians discuss referral to a sleep surgeon with adults who have OSA, BMI <40 kg/m², and are intolerant or unaccepting of PAP therapy 1. Your patient fits this profile precisely with:
- Age ≥22 years (eligibility met)
- BMI ≤35 kg/m² (within the approved range; some sources cite ≤32 kg/m² for certain devices 2)
- AHI 15-65 events/hour (moderate-to-severe OSA)
- CPAP intolerance (documented failure of first-line therapy)
- No complete concentric palatal collapse on DISE (anatomically suitable)
Evidence Supporting Hypoglossal Nerve Stimulation
The most recent high-quality evidence demonstrates robust efficacy:
Meta-analysis (2026): Pooled Sher response rate of 74.0% (95% CI 67.6-79.5%), with significant improvements in AHI (-23.3 events/hour), ESS (-4.5 points), and ODI (-14.5 events/hour) 3
OSPREY Trial (2026): Randomized controlled trial showing 58.2% of treatment patients achieved >50% AHI reduction and AHI <20 events/hour at 7 months, versus only 13.5% in controls. Median ESS improved from 10 to 6 in the treatment group 4
Safety profile: Revision rate 5%, explantation rate 4%, with no serious procedure-related adverse events reported in recent trials 4, 3
Critical Eligibility Requirements
Mandatory pre-operative assessment includes:
- Drug-induced sleep endoscopy (DISE): Must rule out complete concentric collapse at the velum level, which predicts poor response to respiratory-synchronous bilateral stimulation 5, 2
- Exclusion of central/mixed apneas: A significant proportion of central events is a contraindication 5
- BMI verification: Upper limit varies by device (32-35 kg/m²) but your patient meets all published thresholds 5, 2
Treatment Algorithm
Step 1: Confirm CPAP failure is documented (intolerance, non-adherence, or contraindication)
Step 2: Verify patient meets all inclusion criteria:
- Age ≥22 years
- BMI ≤35 kg/m²
- AHI 15-65 events/hour on diagnostic sleep study
- Predominantly obstructive (not central) apneas
Step 3: Refer to experienced sleep surgeon for DISE evaluation to assess:
- Palatal collapse pattern (complete concentric collapse is contraindication)
- Tongue base obstruction (favorable anatomy)
- Lateral pharyngeal wall dynamics
Step 4: If DISE favorable → proceed with implantation
Step 5: Post-operative activation at 1 month, with titration guided by polysomnography at 2-3 months 2
Important Clinical Considerations
Adherence advantage: Studies consistently show superior adherence to hypoglossal nerve stimulation compared to CPAP, which directly impacts real-world effectiveness and long-term outcomes 6, 3
Durability: Clinical benefits appear stable at 36 months, with sustained improvements in AHI, ODI, sleepiness, and quality of life 2
Common pitfall: Proceeding without DISE evaluation. Complete concentric palatal collapse predicts treatment failure and must be excluded pre-operatively 5, 2
Alternative consideration: If BMI is between 32-35 kg/m², verify device-specific eligibility as some systems have stricter BMI limits 2
Multidisciplinary Approach
The European Respiratory Society guideline emphasizes that hypoglossal nerve stimulation should be offered through multidisciplinary centers with expertise in patient selection, surgical technique, and long-term follow-up 2. This ensures optimal outcomes through:
- Rigorous screening with DISE
- Experienced surgical implantation
- Systematic post-operative titration with polysomnography
- Structured follow-up at 1 month, 3 months, then annually 2
Bottom line: This patient is an excellent candidate for Inspire therapy based on current guidelines and should be referred to a sleep surgeon experienced in hypoglossal nerve stimulation for DISE evaluation and potential implantation 1.